Dr. Dragana Orlovic, MD

Dr. Orlovic practices at Thomas Memorial Hospital in South Charleston, West Virginia, part of West Virginia University Health System.

Dr. Orlovic's NPI, 1407824345, was assigned on March 8, 2006. Dr. Orlovic holds West Virginia license 03121.

Dr. Orlovic's primary practice is Thomas Memorial Hospital, at 4605 Maccorkle Avenue SW, South Charleston, WV 25309 in Kanawha County. The practice phone is (304) 766-3600.

Dr. Orlovic's primary practice is Thomas Memorial Hospital in South Charleston, West Virginia, part of West Virginia University Health System. Dr. Orlovic is also affiliated with Charleston Area Medical Center General Hospital. The medical group on file is THS Physician Partners, Inc. Dmand AI also links Dr. Orlovic to 1 more hospital, 1 group practice or clinic and 1 home health agency, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Orlovic practices, 5 sites in all. Vendor and product names are available with a free account.

Infectious disease is Dr. Orlovic's primary specialty in the NPI Registry, under taxonomy code 207RI0200X. Dmand AI has Dr. Orlovic's licenses on file in 2 states: West Virginia and Florida.

CMS data shows 1,060 Medicare services from Dr. Orlovic across 8 procedure codes in 2024, for 221 Medicare patients. Medicare paid $66,809 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 221 Medicare patients who saw Dr. Orlovic in 2024. The largest group is 65 to 74, with 81 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 33% are also on Medicaid. Their average risk score is 2.63, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Orlovic's median patient age at 67, with 47% women.

In 2024, Dr. Orlovic wrote 448 Medicare Part D claims for 110 patients. 80% of them were for generic drugs. CMS names the drug for 370 of them, across 10 drugs with 11 or more claims each, at $258,147 in total drug cost. In 2023, CMS named 163 claims across 7 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 95 out of 100 for Dr. Orlovic for performance year 2024, reported through an alternative payment model (APM). Dr. Orlovic accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Orlovic as offering telehealth.